Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials.

Zhao Y, Zhang F, Yang B, Zhang L, Wu L, Ding Y, Wang J, Li Y, Diao Q, Li J, Sun Q, Zhu X, Man X, Wang L, Feng Y, Cai T, Zeng H, Li L, Lu J, Ren H, Li F, Lu Q, Tao X, Xiao R, Zhang C, Xia X, Cheng H, Ji C, Zhao W, Qiu Y, Chu W, Yan H, Chen B, Zhang J

Open source

DOI
10.1080/09546634.2026.2670906
Published
2026 Dec
Container
The Journal of dermatological treatment
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/09546634.2026.2670906,
  title = {Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials.},
  author = {Zhao Y and Zhang F and Yang B and Zhang L and Wu L and Ding Y and Wang J and Li Y and Diao Q and Li J and Sun Q and Zhu X and Man X and Wang L and Feng Y and Cai T and Zeng H and Li L and Lu J and Ren H and Li F and Lu Q and Tao X and Xiao R and Zhang C and Xia X and Cheng H and Ji C and Zhao W and Qiu Y and Chu W and Yan H and Chen B and Zhang J},
  year = {2026},
  journal = {The Journal of dermatological treatment},
  doi = {10.1080/09546634.2026.2670906},
  url = {https://doi.org/10.1080/09546634.2026.2670906}
}

RIS

TY  - JOUR
TI  - Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials.
AU  - Zhao Y
AU  - Zhang F
AU  - Yang B
AU  - Zhang L
AU  - Wu L
AU  - Ding Y
AU  - Wang J
AU  - Li Y
AU  - Diao Q
AU  - Li J
AU  - Sun Q
AU  - Zhu X
AU  - Man X
AU  - Wang L
AU  - Feng Y
AU  - Cai T
AU  - Zeng H
AU  - Li L
AU  - Lu J
AU  - Ren H
AU  - Li F
AU  - Lu Q
AU  - Tao X
AU  - Xiao R
AU  - Zhang C
AU  - Xia X
AU  - Cheng H
AU  - Ji C
AU  - Zhao W
AU  - Qiu Y
AU  - Chu W
AU  - Yan H
AU  - Chen B
AU  - Zhang J
PY  - 2026
JO  - The Journal of dermatological treatment
DO  - 10.1080/09546634.2026.2670906
UR  - https://doi.org/10.1080/09546634.2026.2670906
ER  - 

APA

Y, Z., F, Z., B, Y., L, Z., L, W., Y, D., J, W., Y, L., Q, D., J, L., Q, S., X, Z., X, M., L, W., Y, F., T, C., H, Z., L, L., J, L., H, R., F, L., Q, L., X, T., R, X., C, Z., X, X., H, C., C, J., W, Z., Y, Q., W, C., H, Y., B, C., & J, Z. (2026). Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials.. The Journal of dermatological treatment. https://doi.org/10.1080/09546634.2026.2670906

Source records